WHO Pre-Qualified (PQ) Vaccine Priority List for 2024-2026
- Deadly Fungus Found Across the US with a 90% Fatality Rate!
- Top 4 Breakthrough Anti-Aging Drugs that Could Extend Your Healthy Years
- Does Iron Supplementation Increase HIV Risk or Improve Brain Development?
- Immunotherapy Could Prevent Heart Attacks from Progressing to Heart Failure
- AstraZeneca Oral Weight Loss Drug: Nearly 6% Weight Reduction in 4 Weeks
- Pfizer’s Abrysvo RSV Vaccine: Expanded Approval and Key Trial Results
WHO Pre-Qualified (PQ) Vaccine Priority List for 2024-2026
- Deadly Fungus Found Across the U.S. with a 90% Fatality Rate!
- Sanofi Japan Data Breach: 730000 Healthcare Professionals’ Information Exposed
- FDA has mandated a top-level black box warning for all marketed CAR-T therapies
- Can people with high blood pressure eat peanuts?
- What is the difference between dopamine and dobutamine?
- How long can the patient live after heart stent surgery?
WHO Pre-Qualified (PQ) Vaccine Priority List for 2024-2026
The “Pre-Qualified Vaccine Priority List” has been established through negotiations between the World Health Organization (WHO), the United Nations Children’s Fund (UNICEF), and the Pan American Health Organization revolving fund. It outlines the WHO PQ priority levels for various vaccines.
The WHO updates the list every two years, categorizing vaccines expected to be available within the two-year period into high, medium, low, and no priority levels.
The prioritization of vaccines guides the WHO in concentrating limited pre-qualification resources on priority vaccines, supporting national immunization programs in achieving their goals.
The previous version of the priority list covered the period from 2018 to 2022. In November 2023, the WHO updated the Pre-Qualified Vaccine Priority List for 2024-2026. This is shared with Chinese vaccine companies, allowing them to apply for PQ for high and medium priority vaccines.
❃ High-Priority Vaccines
-
Cholera Vaccine
-
Dengue Fever Quadrivalent Vaccine
-
Hexavalent Vaccine: Whole-Cell Pertussis-Hepatitis B-Haemophilus influenzae type b-Inactivated Polio Vaccine (DTwP-HepB-Hib-IPV)
-
Human Papillomavirus (HPV) Vaccine
-
Malaria Vaccine
-
Measles-Rubella (MR) Bivalent Vaccine
-
Measles-Mumps-Rubella (MMR) Trivalent Vaccine
-
Meningococcal ACWY Conjugate Vaccine
-
Meningococcal ACWYX Conjugate Vaccine
-
Pneumococcal Conjugate Vaccine
-
Novel Oral Polio Vaccine Type 2 (nOPV2)
-
Rotavirus Vaccine
-
Respiratory Syncytial Virus (RSV) Vaccine
-
Typhoid Conjugate Vaccine
-
Yellow Fever Vaccine
❃ Medium-Priority Vaccines
-
BCG Vaccine
-
Ebola Vaccine
-
Hepatitis A Vaccine
-
Hepatitis B Vaccine
-
Hepatitis E Vaccine
-
Measles Vaccine
-
Oral Bivalent 1,3 Type Polio Attenuated Vaccine (bOPV1,3)
-
Oral Monovalent Type 1 Polio Attenuated Vaccine (mOPV1)
-
Rabies Vaccine
-
Varicella Vaccine
-
Chikungunya Virus Vaccine
❃ Low-Priority Vaccines
-
Diphtheria-Tetanus (DT) Vaccine for Children
-
Diphtheria-Tetanus (Td) Vaccine for Adults
-
Quadrivalent Liquid Whole-Cell Pertussis-Hepatitis B-Haemophilus influenzae type b (DTwP-HepB-Hib) Vaccine
-
Acellular Pertussis-Hepatitis B-Haemophilus influenzae type b-Inactivated Polio Vaccine (DTwP-HepB-Hib-IPV) Hexavalent Vaccine
-
Seasonal Influenza NH and SH Vaccines *
-
Japanese Encephalitis Vaccine
-
Meningococcal Conjugate Vaccine (A)
-
Pneumococcal Polysaccharide Vaccine
-
Inactivated Polio Vaccine (IPV)
-
Sabin Strain Inactivated Polio Vaccine (sIPV)
-
Oral Monovalent Type 2 Polio Attenuated Vaccine (mOPV2)
-
Oral Monovalent Type 3 Polio Attenuated Vaccine (mOPV3)
-
Oral Trivalent Polio Attenuated Vaccine (tOPV)
*Priority can be elevated to medium if faster production technologies are utilized.
❃ No-Priority Vaccines
-
Diphtheria-Tetanus-Whole-Cell Pertussis (DTwP) Vaccine
-
Diphtheria-Tetanus-Acellular Pertussis (DTaP) Vaccine
-
DTwP+Hib (Liquid-Freeze Dried) Quadrivalent Vaccine
-
DTwP-Hib (Liquid) Quadrivalent Vaccine
-
DTwP-Hep B Quadrivalent Vaccine
-
Pentavalent Vaccine Based on DTwP (Liquid-Freeze Dried) (DTwP-Hep B+Hib)
-
Haemophilus influenzae type b (Hib) Vaccine
-
Emergency Reserve Inactivated H1N1 Influenza Vaccine
-
Meningococcal Conjugate Vaccine (CW)
-
Meningococcal Polysaccharide Vaccine (AC)
-
Meningococcal Polysaccharide Vaccine (ACWY)
-
Rubella Vaccine
-
Tetanus Toxoid (TT) Vaccine
-
Typhoid Polysaccharide Vaccine
For vaccines whose development is complete and meets public health needs, the following potential candidates are considered during this biennial period:
-
COVID-19 Vaccine
-
Combined Vaccine for Novel OPV1, 3, and 2 Types
-
Smallpox Vaccine
-
Tuberculosis (TB) Vaccine
-
Shigella Vaccine
-
Group B Streptococcus Vaccine
-
S19-IPV Vaccine
WHO Pre-Qualified (PQ) Vaccine Priority List for 2024-2026
(source:internet, reference only)
Disclaimer of medicaltrend.org
Important Note: The information provided is for informational purposes only and should not be considered as medical advice.